WASHINGTON, July 14 -- Food and Drug Administration has issued a notice called: Considerations for Potential Future Therapeutic Use of Psychedelic Drugs; Public Hearing; Request for Comments.
The notice was published in the Federal Register on July 14 by Grace R. Graham, Deputy Commissioner for Policy, Legislation, and International Affairs.
Summary: The Food and Drug Administration (FDA, the Agency, or we) is announcing a public hearing on the potential future therapeutic use of psychedelic drugs. In collaboration with federal partners, FDA is holding this public hearing to obtain feedback and perspectives on issues associated with the potential future therapeutic use of drug products containing a psychedelic drug substance in supervised...